CIK 0001802665 · Large accelerated filer
Harmony Biosciences Holdings, Inc.
Sign in to watch- Ticker
- HRMY
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 822279923
- Phone
- (484) 539-9800
- Business address
- 630 W GERMANTOWN PIKE, SUITE 215, PLYMOUTH MEETING, PA, 19462
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $3,108,586
- in 2 filings
Net −$3,108,586. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 87 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2025-04-01 | Kapadia Sandip CHIEF FINANCIAL OFFICER | Sale 10b5-1 | −6,247 | $32.48 | $203K | 740 |
| 2025-04-01 | Kapadia Sandip CHIEF FINANCIAL OFFICER | Sale 10b5-1 | −740 | $33.12 | $25K | 0 |
| 2025-03-29 | Kapadia Sandip CHIEF FINANCIAL OFFICER | Option exercise | +15,000 | 15,000 | ||
| 2025-03-29 | Kapadia Sandip CHIEF FINANCIAL OFFICER | Shares withheld for taxes | −8,014 | $33.19 | $266K | 6,986 |
| 2025-03-29 | Kapadia Sandip CHIEF FINANCIAL OFFICER | Option exercise · Restricted Stock Units | −15,000 | 15,000 | ||
| 2025-03-03 | Dierks Jeffrey CHIEF COMMERCIAL OFFICER | Option exercise 10b5-1 | +4,869 | $8.22 | $40K | 4,869 |
| 2025-03-03 | Dierks Jeffrey CHIEF COMMERCIAL OFFICER | Sale 10b5-1 | −4,369 | $32.61 | $142K | 500 |
| 2025-03-03 | Dierks Jeffrey CHIEF COMMERCIAL OFFICER | Sale 10b5-1 | −500 | $33.23 | $17K | 0 |
| 2025-03-03 | Dierks Jeffrey CHIEF COMMERCIAL OFFICER | Option exercise · Stock Option 10b5-1 | −4,869 | 0 | ||
| 2025-01-27 | Dierks Jeffrey CHIEF COMMERCIAL OFFICER | Sale 10b5-1 | −1,629 | $38.02 | $62K | 0 |
| 2025-01-27 | Kapadia Sandip CHIEF FINANCIAL OFFICER | Sale 10b5-1 | −1,775 | $38.05 | $68K | 0 |
| 2025-01-25 | Budur Kumar CHIEF MEDICAL OFFICER | Grant or award · Stock Option | +37,400 | 37,400 | ||
| 2025-01-25 | Budur Kumar CHIEF MEDICAL OFFICER | Grant or award · Restricted Stock Units | +10,650 | 10,650 | ||
| 2025-01-25 | Dierks Jeffrey CHIEF COMMERCIAL OFFICER | Grant or award · Stock Option 10b5-1 | +47,200 | 47,200 | ||
| 2025-01-25 | Dierks Jeffrey CHIEF COMMERCIAL OFFICER | Grant or award · Restricted Stock Units 10b5-1 | +13,450 | 13,450 | ||
| 2025-01-25 | Dayno Jeffrey M. PRESIDENT, CEO | Grant or award · Stock Option | +180,000 | 180,000 | ||
| 2025-01-25 | Dayno Jeffrey M. PRESIDENT, CEO | Grant or award · Restricted Stock Units | +52,000 | 52,000 | ||
| 2025-01-25 | Kapadia Sandip CHIEF FINANCIAL OFFICER | Grant or award · Stock Option 10b5-1 | +66,250 | 66,250 | ||
| 2025-01-25 | Kapadia Sandip CHIEF FINANCIAL OFFICER | Grant or award · Restricted Stock Units 10b5-1 | +18,900 | 18,900 | ||
| 2025-01-25 | Serafin Andrew CHIEF STRATEGY OFFICER | Grant or award · Stock Option | +36,500 | 36,500 |
Page 6 of 14 · 268 trades